Heart Disease


Women’s IschemiA TReatment Reduces Events In Non-ObstRuctive CAD

WARRIOR is a four-year, multicenter clinical trial to determine whether aggressive treatment of nonobstructive coronary artery disease (CAD) with medication and lifestyle modification will reduce the likelihood of major adverse events such as stroke, heart attack, heart failure, hospitalization, and death.

WARRIOR Web site for more information about non-obstructive CAD and the trial


WARRIOR on clinicaltrials.gov


This is an observational trial for women presenting to the hospital for a heart attack and do not have obstructive coronary artery disease after undergoing cardiac catheterization. This trial is using various cardiac imaging techniques to improve understanding about plaque and coronary artery disease in women. This trial will last 3 years. Please contact 352.273.8933 or email ufcardiovascularct@medicine.ufl.edu for more information.